Mehul S. Suthar
Emory & Henry College
H-index: 69
North America-United States
Top articles of Mehul S. Suthar
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment (preprint) | bioRxiv | Meenakshi Kar Katherine EE Johnson Abigail Vanderheiden Elizabeth J Elrod Katharine Floyd | 2024 |
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans | Science Immunology | Lilit Grigoryan Yupeng Feng Lorenza Bellusci Lilin Lai Bushra Wali | 2024/4/5 |
XBB. 1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants | bioRxiv | Shilpi Jain Sanjeev Kumar Lilin Lai Susanne Linderman Ansa A Malik | 2024 |
Single-cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells | Journal of Virology | Kathryn M Moore Adam-Nicolas Pelletier Stacey Lapp Amanda Metz Gregory K Tharp | 2024/4/3 |
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance | Nature Immunology | Audrey Lee Katharine Floyd Shengyang Wu Zhuoqing Fang Tze Kai Tan | 2024/1 |
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants | Pediatrics | Cristina V Cardemil Yi Cao Christine M Posavad Martina L Badell Katherine Bunge | 2024/3/1 |
Immunogenicity and efficacy of XBB. 1.5 rS vaccine against EG. 5.1 variant of SARS-CoV-2 in Syrian hamsters | Jacco Boon Nadia Soudani Traci Bricker Tamarand Darling Kuljeet Seehra | 2024/2/9 | |
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques | Nature | Katherine McMahan Frank Wegmann Malika Aid Michaela Sciacca Jinyan Liu | 2024/2/8 |
Patients on Benralizumab, Dupilumab, or Mepolizumab Have Lower Post-vaccination SARS-CoV-2 Immunity | P Lamothe M Runnstrom C Faliti N Cheedarla A Moreno | 2024/5 | |
Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2 | Cell Reports | Julia Z Adamska Rohit Verma Shakti Gupta Thomas Hagan Florian Wimmers | 2023/1/17 |
Development of a definition of postacute sequelae of SARS-CoV-2 infection | Jama | Tanayott Thaweethai Sarah E Jolley Elizabeth W Karlson Emily B Levitan Bruce Levy | 2023/6/13 |
Ad26. COV2. S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA. 5 challenge in macaques | Cell Reports Medicine | Jingyou Yu Paul V Thomas Michaela Sciacca Cindy Wu Jinyan Liu | 2023/4/18 |
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity | Research Square | Alberto Moreno Kelly Manning Maryam I Azeem Ajay K Nooka Madison Ellis | 2023/8/22 |
Mucosal adenoviral-vectored vaccine boosting durably prevents XBB. 1.16 Infection in nonhuman primates | bioRxiv | Matthew Gagne Barbara J Flynn Shayne F Andrew Dillon R Flebbe Anna Mychalowych | 2023/11/8 |
IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus | Science Advances | Harshad Ingle Heyde Makimaa Somya Aggarwal Hongju Deng Lynne Foster | 2023/9/13 |
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2 | bioRxiv | Yupeng Feng Meng Yuan John M Powers Mengyun Hu Jennifer E Munt | 2023/1/20 |
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies | Blood advances | Andres Chang Jean L Koff Lilin Lai Victor M Orellana-Noia Minal Surati | 2023/6/13 |
Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice | EMBO reports | Adam D Kenney Ashley Zani Jeffrey Kawahara Adrian C Eddy Xiao‐Liang Wang | 2023/4/5 |
Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques | Journal of Neuroimmunology | Alejandra Medina Rebecca Rusnak Rebecca Richardson Matthew G Zimmerman Mehul Suthar | 2023/8/15 |
Patients on mepolizumab, benralizumab, or dupilumab have diminished post-vaccination antibody and B cell responses to SARS-CoV-2. | Pedro Lamothe Martin Runnstrom Katia Faliti Narayanaiah Cheedrala Alberto Moreno | 2023/9/9 |
Co-Authors
